Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

2025 Updates on Thyroid Cancer Management

UNC Lineberger Comprehensive Cancer Center

C. Blake Sullivan

Year in Review 2024 - Head & Neck Cancers

Oncology 2024 Year in Review

P. Bossi

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

AAO 2024 Insights: MRI in Ocular Oncology

AAO 2024 Insights

R. Bansal

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

ESMO 2024 Insights: H&N Cancer Brief Overview and KEYNOTE-048 Trial …

2024 ESMO Annual Meeting Insights Hub

C. Olazagasti

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

Expert Perspectives on Key Trial Insights and Treatment Updates in H…

Yale Cancer Center

B. Burtness

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

Improving Patient Outcomes With Innovations in Endocrine Surgery: Tr…

Yale Cancer Center

E. Winer, J. Ogilvie

Quality of Life for the Head and Neck Cancer Survivor

Apoorva Ramaswamy

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

2024 ASCO® Annual Meeting Insights Hub

K. Kerrigan

Cancer Screening Molecular Tools

Fengting Yan

Additional Advances in HNSCC: Immunotherapy & Targeted Treatments

Oncology Data Advisor

D. Wong

Common Sense Oncology in Head & Neck Cancers

ecancer

A. D'Cruz